Peter Ellmark

Peter Ellmark

Company: Alligator Bioscience AB

Job title: Chief Science Officer

Seminars:

Clinical Case Study: CD40-Mediated Activation of Myeloid Cells to Drive Anti-Tumor Immunity to Enhance the Overall Anti-Tumor Effects 9:30 am

CD40-mediated activation of myeloid cells is a promising approach for enhancing antitumor immunity CD40-mediated activation directs the immune system toward recognizing and attacking tumor-specific antigens CD40-mediated activation can synergize with existing cancer therapies, combinatorial approaches with checkpoint inhibitors or chemotherapy enhance overall anti-tumor effectsRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.